The HLA (Human Leukocyte Antigen) system helps the immune system distinguish self from foreign antigens. Abnormalities or specific variants in this system are often linke
The HLA-B5-B51 Locus Test is an advanced genetic analysis used to identify the presence of HLA-B5 and HLA-B51 alleles within the human leukocyte antigen (HLA) system. This test is essential for evaluating genetic susceptibility to autoimmune and inflammatory conditions, particularly Behçet’s disease.
At Diagnopein Diagnostic Centre Nashik, our certified molecular biology team performs HLA typing with precision using advanced PCR and sequencing technologies to deliver highly reliable genetic results.
The HLA-B5-B51 locus plays a critical role in immune regulation and disease susceptibility. The HLA-B51 allele has been identified as a genetic risk factor for Behçet’s disease and other autoimmune conditions, including inflammatory bowel disease and vasculitis. Detecting this allele through reliable laboratory testing helps clinicians predict immune dysfunction early.
At Diagnopein Diagnostic Centre Nashik, detecting the HLA-B5-B51 variant provides crucial insights into genetic predisposition. For individuals showing symptoms like recurrent oral ulcers, eye inflammation, or unexplained systemic inflammation, this test can be a turning point in personalized healthcare management.
Identifies genetic risk for Behçet’s disease and vasculitic conditions.
Helps in designing targeted and preventive healthcare plans.
Supports clinicians in differential diagnosis for autoimmune diseases.
Contributes to organ and stem cell transplantation compatibility assessments.
Provides valuable genetic counseling data for families with autoimmune disease history.
Diagnopein’s scientifically validated methods allow for genetic precision that enhances patient safety and decision-making.
Diagnopein Diagnostic Centre Nashik specializes in molecular immunogenetic testing that combines accuracy, affordability, and fast reporting. Our HLA-B5-B51 Locus Test delivers clinical-grade genetic insights verified by molecular experts and advanced PCR-based testing setups.
High accuracy and reliability: Advanced PCR systems ensure precise identification of HLA-B5 and HLA-B51 alleles.
Early detection support: Identifies risk factors before clinical symptoms worsen.
Non-invasive procedure: Requires only a small blood sample for analysis.
Timely reporting: Comprehensive reports are typically ready within 5–7 working days.
Expert interpretation: Genetic counsellors guide physicians and patients through the results.
Affordable testing packages: Tailored cost-effective options for patients in Nashik and nearby regions.
Diagnopein Nashik’s laboratory infrastructure is equipped with modern molecular diagnostic technology to ensure top-tier accuracy in every test. Patients and healthcare professionals trust our expertise for dependable diagnosis and early genetic prediction.
At Diagnopein Nashik, the HLA-B5-B51 Locus Test follows a robust, quality-assured procedure for consistency and accuracy. The testing is based on molecular amplification of specific DNA regions associated with HLA-B5 and HLA-B51 alleles.
Sample collection: A small blood sample (2–5 mL) is collected in an EDTA tube.
DNA extraction: Genomic DNA is purified from white blood cells.
PCR amplification: Target alleles of the HLA-B locus are amplified using allele-specific primers.
Genotype analysis: DNA patterns are compared with reference sequences.
Result interpretation: Reports specify the presence or absence of HLA-B5 and HLA-B51 alleles.
Detection of HLA-B5 allele.
Identification of HLA-B51 allele subtype.
Genetic correlation with autoimmune and inflammation markers.
Analysis of HLA-B genetic variation for clinical evaluation.
The test typically requires no special preparation, and results are evaluated by molecular biologists before physician review. Diagnopein prioritizes confidentiality, accuracy, and timely delivery for every patient.
Healthcare practitioners may recommend the HLA-B5-B51 Locus Test under these conditions:
Recurrent mouth or genital ulcers.
Chronic skin inflammation or vascular disorders.
Unexplained immune system hyperactivity.
Family history of Behçet’s disease or autoimmune disorders.
Genetic risk profiling prior to organ transplantation.
For those living in and around Nashik, Diagnopein offers an easily accessible, professional platform for molecular diagnostic services that help determine genetic risk factors early.
Diagnopein Diagnostic Centre Nashik stands as a leader in genetic, molecular, and diagnostic innovation. Our lab adheres to international standards, and every test result undergoes review by expert pathologists and genetic technologists.
Diagnopein ensures:
Accredited and well-equipped testing facilities.
Trained technical staff and qualified molecular specialists.
Personalized patient support and interpretation of test reports.
Affordable healthcare with high diagnostic accuracy.
Easy appointment booking and home sample collection services in Nashik.
With an unwavering commitment to quality healthcare and genetic precision, Diagnopein Nashik continues to serve as a trusted choice for advanced HLA testing, providing reliable results that help patients and doctors make confident decisions.
A healthcare professional will collect a blood sample, usually from a vein in the arm, and send it to a laboratory for analysis.
Limitations include the potential for false results, the need for comprehensive clinical evaluation alongside the test, and the fact that a positive result does not confirm a diagnosis on its own.
The test involves a blood sample from which DNA is extracted. Techniques such as polymerase chain reaction (PCR) are used to amplify and identify the specific HLA B5 and B51 alleles present in the DNA.
This test is important for diagnosing autoimmune diseases, particularly Behçet's disease, which has a strong association with the HLA B51 allele. Identifying these alleles can help guide treatment decisions and risk assessment.
